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Background: Assisted injection is common among people who inject drugs (IDU), and has been associated with
elevated risk for HIV infection and overdose. However, this practice has not been explored in the Asian context,
including in Thailand, where HIV prevalence among IDU remains high.
Methods: Using multivariate logistic regression, we examined the prevalence and correlates of assisted injecting
among IDU participating in the Mitsampan Community Research Project in Bangkok. We also sought to identify
reasons for engaging in assisted injecting and those who provide this form of assistance.
Results: In total, 430 IDU participated in this study, including 376 (87.5%) who reported having ever required
assistance injecting, and 81 (18.8%) who reported assisted injecting in the previous six months. In multivariate
analyses, assisted injecting in the previous six months was independently and positively associated with
being female (adjusted odds ratio [AOR] = 2.42; 95% confidence interval [CI]: 1.40 – 4.18), being a weekly heroin
injector (AOR = 1.78; 95% CI: 0.99 – 3.20), syringe sharing (AOR = 2.08; 95% CI: 1.18 – 3.68) and soft-tissue infection
(AOR = 3.51; 95% CI: 1.43 – 2.53). Having a longer injecting career (AOR = 0.96; 95% CI: 0.94 – 0.99) was negatively
associated with assisted injecting. Primary reasons given for engaging in assisted injecting included being new to
injecting and lacking knowledge on how to inject. The most common providers of assistance with injecting were
close friends.
Conclusion: We found a high prevalence of assisted injecting among IDU in Bangkok, with females, frequent
heroin injectors, those with shorter injecting careers being more likely to engage in this practice. Those who require
help with the injecting process are more likely to share syringes, and have skin infections. These findings indicate
the need for interventions focused on promoting safer and self-administered injections.
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The injection of illicit drugs remains an international
public health concern and has been associated with the
transmission of the human immunodeficiency virus
(HIV) and other serious health-related problems [1,2].
As such, various harm reduction strategies, including
needle distribution programs, have been implemented to
mitigate high-risk behaviors such as syringe sharing,
which contribute to the spread of blood-borne diseases* Correspondence: uhri-tk@cfenet.ubc.ca
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stated.[3-6]. Despite these measures, people who inject drugs
(IDU) continue to be exposed to a range of drug-related
harms [7].
In North American settings, the provision of manual
assistance with injections among people who inject
drugs (IDU) has received increasing attention, as it has
been demonstrated to be independently associated with
elevated risk for blood-borne disease transmission, infec-
tions, non-fatal overdose and other health-related prob-
lems [4,8]. One study indicated that syringe sharing – a
behavior strongly associated with HIV transmission – is
four times more likely to occur among those who re-
ceive help with drug injections than regular IDU, as the
“street doctors” (injectors) are likely to reuse a needle. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
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injecting others [4]. Furthermore, Kral et al. found that
the use of blood-contaminated materials such as used
cottons or thumbs to clean the injection site is more
commonly observed among those who receive help with
their injections compared to those who self-administer
their injections in the San Francisco Bay area [4]. Such a
behavior allows for possible routes of HCV (Hepatitis C
Virus) and possibly HIV transmission to occur. Skin-
popping (i.e., injecting subcutaneously or intramuscu-
larly) was also more likely to occur among IDU who
receive help with their injections. This behavior has been
associated with a higher risk of acquiring skin infections
such as abscesses and necrotizing fasciitis [9]. The prac-
tice of assisted injecting has been found to be more
common among women, those who are newer to
injecting, and frequent cocaine injectors [8,10]. Several
reasons for requiring help injecting have been identified
and include perceived loss of accessible veins, difficulty
with injecting because of shaky hands, and lack of famil-
iarity with injection techniques [8].
Although assisted injecting has been identified in vari-
ous settings as being a high-risk behavior, this practice
has not been explored in the Asian context, including in
Thailand where HIV prevalence among IDU has
remained persistently high [11]. In an effort to inform
related public health responses, this study aims to iden-
tify the prevalence and correlates of assisted injecting
among IDU in Bangkok, Thailand. We also sought to
identify reasons for needing assistance with injecting
and those who typically provide this type of assistance.
Methods
Study design
Data for this study were derived from the Mitsampan
Community Research Project, a collaborative research
effort involving the Mitsampan Harm Reduction Center
(MSHRC), a drug user–run drop-in centre in Bangkok,
Thailand, the Thai AIDS Treatment Action Group
(Bangkok, Thailand), Chulalongkorn University (Bangkok,
Thailand), and the British Columbia Centre for Excellence
in HIV/AIDS/University of British Columbia (Vancouver,
Canada).
Between July and October of 2011, the research part-
ners recruited and surveyed 440 IDU. Potential partici-
pants were recruited through peer outreach efforts and
word-of-mouth, and were invited to attend the MSHRC
or O-Zone House (another drop-in centre in Bangkok)
in order to be part of the study. Adults residing in
Bangkok or in adjacent provinces who had injected
drug(s) in the past six months were eligible for participa-
tion. All participants provided informed consent and com-
pleted an interviewer-administered questionnaire eliciting
a range of information, including socio-demographiccharacteristics, drug use patterns, and experiences with
drug law enforcement and accessing healthcare. Peer re-
searchers (i.e., current and former IDU) trained to conduct
outreach were sent offsite in pairs to areas with a high
density of IDU to recruit participants. Potential partici-
pants were given information cards with directions to the
MSHRC or O-Zone House and further contact instruc-
tion. All participants provided informed consent and com-
pleted an interviewer-administered questionnaire eliciting
a range of information, including socio-demographic
characteristics, drug use patterns, and experiences with
drug law enforcement and accessing healthcare. The ques-
tionnaire was administered by a group of peer researchers
who underwent proper and extensive training by frontline
staff from the BC Centre for Excellence in HIV/AIDS.
Upon completion of the questionnaire, participants re-
ceived a stipend of 350 Thai baht (approximately US$12).
The study was approved by the research ethics boards at
Chulalongkorn University and the University of British
Columbia.
For the present analyses, the primary outcome of
interest was reporting assisted injecting in the past six
months by responding “always”; ”most of the time”;
“sometimes” or “not very often” (as opposed to “never”)
to the question: “In the last 6 months, how often did
anyone help you inject?” We considered several potential
explanatory variables of interest, including: gender
(female vs. male); median age (≥ 38 years vs. < 38 years);
education (≥ secondary education vs. < secondary educa-
tion); relationship status (married or having a regular part-
ner vs. other); heroin injection (> weekly vs. ≤ weekly vs. no
injection), midazolam injection (> weekly vs. ≤ weekly vs.
no injection); methamphetamine “yaba” injection (≥ weekly
vs. ≤ weekly vs. no injection), crystal methamphetamine
“ice” injection (≥ weekly vs. ≤ weekly vs. no injection),
lent or borrowed syringes to/from others (yes vs. no);
used drugs in combination (yes vs. no) length of
injecting career (per year longer), non-fatal overdose
(yes vs. no) and soft-tissue infections (yes vs. no). All
variables referred to the previous six months unless
otherwise indicated. The covariates in our study were
chosen based on a number of studies in the North
American context that suggest significant and inde-
pendent associations with assisted injecting [10].
Bivariate statistics and multivariate logistic regression
were applied to identify factors associated with assisted
injecting. Categorical explanatory variables were ana-
lyzed using Pearson’s Chi-square test and Fisher’s exact
test (when one or more cells contained values less than
or equal to five), and continuous variables were analyzed
using simple logistic regression. We then applied an
a priori-defined statistical protocol based on examin-
ation of the Akaike Information Criterion (AIC) and
p-values to construct an explanatory multivariate logistic
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model including all variables significantly associated with
the outcome at p ≤ 0.10 in bivariate analyses. After the
AIC of the model was noted, subsequent variables with
the largest p-value were individually removed and a re-
duced model was built. We continued this iterative
process until a combination of variables with the lowest
p-value yielded the lowest possible AIC value. All
p-values were two-sided.
In secondary analyses, participants who ever reported
requiring help injecting were asked why they needed
help injecting. Furthermore, these participants were
asked who provided them assistance with injecting.
These data are presented using descriptive statistics.
Results
In total, 430 IDU, including 83 (19.3%) females, provided
complete data and were included in this analysis. The
median age of participants was 38 years (interquartile
range: 34 – 48 years). In total, 376 (87.4%) reported hav-
ing ever required assistance injecting, while 81 (18.8%)
participants reported that they had engaged in assisted
injection in the last six months. Among those who have
reported needing help injecting in the last 6 months, 12
(14.8%) said they always required help, 10 (12.3%) said
they needed help most of the time, 25 (30.9%) required
help some times, and 34 (42.0%) did not require assist-
ance very often.
As shown in Table 1, in bivariate analyses, factors
positively associated with assisted injecting at the 0.10
level included being female (odds ratio [OR] = 2.42; 95%
confidence interval [CI]: 1.40 – 4.18), heroin injection of
more than once a week (OR = 1.78; 95% CI: 0.99 – 3.20),
being in a relationship (OR = 1.60; 95% CI: 0.98 – 2.59),
shared syringes (OR = 2.08; 95% CI: 1.18 – 3.68), used
drugs in combination (OR = 1.53; 95% CI: 0.92 – 2.53) and
soft-tissue infections (OR = 3.51; 95% CI: 1.43 – 8.64). Fac-
tors negatively associated with assisted injecting included
being older or equal to the age of 38 (OR = 0.52; 95%
CI: 0.32 – 0.84), heroin injection once a week or less
(OR = 0.61; 95% CI: 0.33 – 1.10) and having a longer injec-
tion career (OR = 0.96; 95% CI: 0.94 – 0.99).
As indicated in Table 2, in multivariate analyses,
assisted injecting remained independently associated
with being female (AOR = 2.45; 95% CI: 1.33 – 4.48),
being a frequent heroin injector (AOR = 1.41; 95%
CI: 1.01 – 1.98), syringe sharing (AOR = 2.17; 95%
CI: 1.18 – 3.94) and soft-tissue infections (AOR = 3.02;
95% CI: 1.14 – 7.72). Having a longer injecting career
(AOR = 0.97; 95% CI: 0.94 – 0.99) remained negatively
associated with assisted injecting.
The two most common self-reported reasons for re-
quiring assistance with injecting include being new to
injecting (68.7%) and not knowing how to inject (56.1%),and 21.8% attributed bad veins as being a reason for why
they needed help injecting. Less common reasons for re-
quiring assistance injecting include requiring groin injec-
tion (9.7%), having shaky hands (5.8%), being drug-sick
(4.1%), and hating needles (3.4%). Finally, of the partici-
pants who ever needed assistance with injecting, 327
(84.9%) received assistance from a close friend, 42
(10.9%) reported receiving help from a regular partner,
followed by 33 (8.6%) who received assistance from an
acquaintance.
Discussion
In the present analysis, we found that approximately
88% of a community-recruited sample of IDU in
Bangkok had reported previously needing assistance to
inject drugs, and 19% reporting receiving assistance with
an injection in the past six months. In multivariate ana-
lyses, we found five variables that remained positively
and independently associated with assisted injecting.
Soft-tissue infection was the variable most strongly asso-
ciated with the outcome, with people who have soft-
tissue infections being approximately three times more
likely to need assistance with injecting. Those who are
female and those who have shared syringes were both
found to be more than twice as likely to engage in
assisted injecting. Frequent heroin injectors were about
1.5 times more likely to require help with injecting.
Lastly, having a longer injecting career was slightly nega-
tively associated with assisted injecting. The most com-
mon reasons given for requiring assisted injecting are
not knowing how to inject and being new to injecting.
Despite the fact that this is, to our knowledge, the first
study to explore the practice of assisted injecting in
Thailand, some of our findings are consistent with a
large body of literature on assisted injecting in North
American settings [6,8,10]. For instance, we found that
female IDU were approximately twice as likely to engage
in assisted injecting compared to male IDU. This may be
partly explained by the gender dynamics common
among IDU populations, whereby men often retain con-
trol over the possession and administration of drugs
[12-14]. Accordingly, women are often injected by male
friends [5], and as a consequence often do not learn how
to self-administer their injections. In a study conducted
by Fairbairn and colleagues in Canada, women gave nar-
rative accounts of assisted injecting, detailing the oppor-
tunity to share the injecting process and drug high with
men, hence fostering an increased sense of trust and in-
timacy [15]. Another reason that females in the Thai
context might be more than twice as likely to engage in
assisted injecting than males is because females naturally
have smaller veins and may not know how to inject
themselves, as has been shown in other settings [5]. Al-
though many other studies have shown the importance
Table 1 Bivariate analyses of factors associated with assisted injecting in the past six months among IDU in Bangkok,
Thailand (n = 430)
Required help injecting*
Characteristic Yes 81 (18.8%) No 349 (81.2%) Odds ratio (95% CI) p - value
Median Age
≥ 38 years 32 (39.5) 195 (55.9) 0.51 (0.31 – 0.84) 0.008
< 38 years 49 (60.5) 154 (44.1)
Gender
Female 26 (32.1) 57 (16.3) 2.42 (1.40 – 4.18) 0.001
Male 55 (67.9) 292 (83.7)
Education
≥ Secondary education 51 (63.0) 212 (60.7) 1.10 (0.67 – 1.81) 0.712
< Secondary education 30 (37.0) 137 (39.3)
Relationship status
Married or having a regular partner 44 (54.3) 149 (42.7) 1.60 (0.98 – 2.59) 0.058
Other 37 (45.7) 200 (57.3)
Heroin injection*
>Weekly 27 (33.3) 64 (18.3) 1.78 (0.99 – 3.20) 0.054
≤Weekly 21 (25.9) 146 (41.8) 0.61 (0.33 – 1.10) 0.096
No injection 33 (40.7) 139 (39.8)
Midazolam injection*
>Weekly 42 (51.9) 195 (55.9) 0.92 (0.52 – 1.63) 0.776
≤Weekly 17 (21.0) 60 (17.2) 1.21 (0.59 – 2.46) 0.598
No injection 22 (27.2) 94 (26.9)
Yaba injection*
>Weekly 16 (19.8) 72 (20.6) 1.08 (0.57 – 2.04) 0.818
≤Weekly 25 (30.9) 83 (23.8) 1.46 (0.83 – 2.56) 0.185
No injection 40 (49.4) 194 (55.6)
Ice injection*
>Weekly 2 (2.5) 17 (4.9) 0.50 (0.11 – 2.21) 0.546
≤Weekly 10 (12.3) 39 (11.2) 1.09 (0.52 – 2.29) 0.847
No injection 69 (85.2) 293 (84.0)
Shared syringes*
Yes 22 (27.2) 53 (15.2) 2.08 (1.18 – 3.68) 0.011
No 59 (72.8) 296 (84.8)
Number of years injecting
Median (IQR) 17 (8 – 21) 19 (15 – 27) 0.96 (0.94 – 0.99) 0.003
Non-fatal overdose*
Yes 4 (4.9) 11 (3.2) 1.60 (0.50 – 5.15) 0.498
No 77 (95.1) 338 (96.8)
Used drugs in combination*
Yes 53 (65.4) 193 (55.3) 1.53 (0.92 – 2.53) 0.097
No 28 (34.6) 156 (44.7)
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Table 1 Bivariate analyses of factors associated with assisted injecting in the past six months among IDU in Bangkok,
Thailand (n = 430) (Continued)
Soft-tissue infections*
Yes 9 (11.1) 12 (3.4) 3.51 (1.43 – 8.64) 0.004
No 72 (88.9) 337 (96.6)
IDU people who inject drugs, CI confidence interval, IQR interquartile range.
*Activities/behaviors in the previous six months.
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among women, it is important to note that being in a re-
lationship, a status sometimes associated with trust and
intimacy, was not independently associated with assisted
injecting in our study. This inconsistency further high-
lights the need to explore gender dynamics, outside of
intimate relationships, and the impact of such dynamics
on assisted injecting among female IDU in Thailand.
Our study also found that more experienced IDU were
less likely to require help injecting. These findings are
further reflected in our sub-analyses where the most
common reasons given for needing assistance with
injecting were being new to injecting and not knowing
how to inject. Our multivariate analysis also supports
this finding by demonstrating that IDU who had
shorter injection careers were more likely to require as-
sistance with injection. These results are consistent with
O’Connell et al.’s [10] study on assisted injecting as a
predictor for HIV infection among IDU in Vancouver
which found that younger IDU and more recent initiates
to injecting were more at risk to requiring assistance
injecting. Furthermore, Wood et al.’s [6] findings on
Vancouver IDU mirror our results, in that 7% of men and
13% of women in that study attributed requiring assist-
ance with injecting to not knowing how to inject properly.
Our study found that frequent heroin injectors were
more likely to engage in assisted injecting compared to
less frequent heroin injectors. However, research in
North America points to frequent stimulant use (cocaineTable 2 Multiple logistic regression of factors associated with
(n = 431)
Variable Adjusted odds ratio
Gender
(Female vs. Male) 2.45
Heroin injection*
(>Weekly vs. ≤Weekly vs. No injection) 1.41
Number of years injecting
(Per year longer) 0.97
Shared syringes*
(Yes vs. No) 2.17
Soft-tissue infections*
(Yes vs. No) 3.02
IDU people who inject drugs.
*Activities/behaviors in the previous six months.use in particular) as being more strongly associated with
assisted injecting [8,16]. On the other hand, previous re-
search has also identified withdrawal effects (i.e., “drug
sickness”) as a reason for assisted injecting [6], and this
type of withdrawal is more commonly associated with
heroin injecting. This geographical variance observed
herein could possibly be accounted for by the fact that
there are different drug use patterns across different
geographical regions. For example, it is well known that
cocaine injecting is virtually non-existent among Thai
IDU [17].
Our findings indicate that those who are recipients of
injections are more likely to have soft-tissue infections
such as abscesses. Several publications have stated that a
strong risk factor for skin infections is skin-popping,
where the injection is intramuscular or subcutaneous
[4,18]. Although intravenous injection carries its own
risks, intramuscular injections allow infections to occur
because foreign substances are introduced directly into
the tissue where it remains localized and concentrated,
providing it with an opportunity to fester and infect the
skin. It is possible that skin-popping is more commonly
observed among Thai IDU who are recipients of injec-
tions because those who administer the injection may
not know how to inject properly themselves. This
phenomenon could be social in origin, where younger
and novice injectors tend to use drugs with their friends
who coincidentally would be closer in age to each other
and have similar drug-use experience.assisted injecting among IDU in Bangkok, Thailand
(AOR) 95% confidence interval (CI) p - value
(1.33 – 4.48) 0.004
(1.01 – 1.98) 0.043
(0.94 – 0.99) 0.022
(1.18 – 3.94) 0.011
(1.14 – 7.72) 0.022
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loss of control of the injection process, which can lead
to risky behaviors such as syringe sharing and the over-
administration of a drug, which can lead to overdose
[8,19]. Although syringe sharing among Thai IDU was
strongly associated with having engaged in assisted
injecting, non-fatal overdose was not significantly associ-
ated with requiring help injecting, which runs counter to
the findings from the North America context [8]. Ac-
cordingly, more research is needed to identify the impact
of assisted injecting on overdose risk among Thai IDU.
Collectively, our findings highlight the need for inter-
ventions that reduce the practice of receiving assisted
injecting among Thai IDU. For this reason, based on our
findings that syringe sharing is independently associated
with assisted injection among Thai IDU, it would be
beneficial to encourage the wide implementation of such
programs in the Thai context. However, based on our
current knowledge and the present findings [6,8], the
provision of sterile injection equipment alone would do
little to avert the practice of assisted injecting altogether.
In addition to the provision of clean equipment and edu-
cation on safe injection, other harm reduction strategies
such as supervised injection facilities (SIFs) may be help-
ful in both reducing the harmful effects that accompany
assisted injecting, such as HIV transmission, overdose,
public drug use, and reducing the prevalence of this
practice altogether [20-23]. Evaluations have found that
staff within SIFs often provide education on safer injec-
tion techniques, and increases in safer injection practices
among high-risk IDU have been associated with expos-
ure to SIFs [8].
However, it should be noted that at most SIFs, assist-
ance provided to IDU who need assistance with injection
is limited to verbal directions and minimal manual as-
sistance (excluding the actual act of injection). Some
IDU are able to conduct the injection successfully fol-
lowing the receipt of such support, but there still remain
a number who are unable to properly inject, and conse-
quently seek out other IDU to assist with the injection
[16]. Therefore, the policies and rules surrounding
assisted injection in SIFs deserve further investigation
[24]. In addition, given that SIFs have not yet been
implemented at all in low- and middle-income settings,
a site assessment in Bangkok on the feasibility and
effectiveness of operating a SIF should be conducted
first. For example, the IDU population in Bangkok may
be too dispersed geographically, and therefore a micro-
environmental intervention of this kind may not reach
high levels of coverage [25]. Further, a lack of key stake-
holder support may serve to undermine the effectiveness
of such an approach.
Female and novice IDU attributed requiring help
injecting to not knowing how to inject properly. Withthe provision of appropriate educational support, this
specific group of IDU can benefit from learning proper
injecting. For those IDU who continue to receive assist-
ance with injections, they may be able to learn about the
deleterious effects of using previously used equipment,
including the elevated risk of disease transmission. Such
educational preventative measures have been docu-
mented in the North American context and have been
shown to be effective [26,27]. However, it should be
noted that the current trend is that messages of safe in-
jection assume self-administered injections, thus future
educational campaigns could shift their focus and be
aimed at those who specifically receive or deliver injec-
tions. Given that drug use remains heavily criminalized
in Thailand, and IDU experience many social barriers to
healthcare, peer-based educational programming may be
most effective in addressing the problem of assisted
injecting in this setting.
This study has limitations. First, the study sample was
not randomly selected and therefore may not be repre-
sentative of all local IDU. Hence, this study may not be
generalizable to Thai IDU or IDU in other settings. How-
ever, given that no accessible official registries of IDU exist
in this setting, deriving a random sample was not possible.
Second, the study relied on self-reported data, which may
be subject to response biases. Third, the study was cross-
sectional in nature, and therefore we were unable to deter-
mine temporal relationships between the outcome and
explanatory variables considered.
In conclusion, we found that approximately 88% of
IDU in Bangkok reported a history of assisted injecting,
and 18% reported receiving assistance with injecting in
the previous six months. Those engaging in assisted
injecting were more likely to be female and frequent her-
oin injectors. Those with longer injecting careers were
less likely to report assisted injecting. A lack of know-
ledge of how to inject was the most common reason given
for engaging in the practice. Assisted injecting among this
population was also strongly associated with syringe shar-
ing and soft-tissue infections. These findings point to the
need for program development within Thailand to reduce
the risks and health consequences associated with assisted
injecting. More specifically, efforts should be made to
widely implement educational and peer-based interven-
tions focused on safer injecting in this setting.Competing interests
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